Health Frontline

City Therapeutics raises $200 million in IPO

October 17, 2026 • Whitney Blake

City Therapeutics' biotech IPO raised $200 million, selling 11.1 million shares on Nasdaq under ticker CTY and expanding RNAi beyond liver disease.